Related Experiment Videos
Metastases to temporal bones from primary nonsystemic malignant neoplasms.
T I Gloria-Cruz1, P A Schachern, M M Paparella
1Department of Otolaryngology, School of Medicine, University of Minnesota, Minneapolis, USA.
Archives of Otolaryngology--Head & Neck Surgery
|February 19, 2000
Summary
Temporal bone metastases are more common than previously thought, particularly from breast cancer. Adequate cancer treatment may prevent temporal bone involvement, highlighting the importance of early cancer management.
Area of Science:
- Otolaryngology
- Pathology
- Oncology
Background:
- Metastasis to the temporal bone is a rare but significant complication of cancer.
- Previous reports on temporal bone metastases lack comprehensive histopathological and clinical data.
Purpose of the Study:
- To compare histopathological and clinical findings of temporal bone metastases with existing literature.
- To determine the prevalence of temporal bone metastases in patients with non-systemic cancer.
- To identify common primary tumor types and patterns of spread to the temporal bone.
Main Methods:
- Retrospective analysis of autopsy records from 864 patients.
- Histopathological evaluation of temporal bones for metastasis and tumor characteristics.
- Review of clinical records for demographic data, clinical course, and otologic manifestations.
Main Results:
- 47 out of 212 patients (22.2%) with non-systemic cancer had temporal bone metastases.
- Breast cancer was the most common primary tumor.
- Hearing loss was the most frequent otologic symptom (40%), but 36% had no symptoms.
- Metastases were bilateral in 62% of cases, commonly spread hematogenously to the petrous apex (82.9%).
- No temporal bone involvement was observed when the primary tumor was adequately treated.
Conclusions:
- Temporal bone metastases are more frequent than previously reported.
- Adequate treatment of the primary tumor appears to prevent temporal bone metastasis.
- Metastatic disease should be considered in patients with hearing loss and a history of cancer.